Science Explorer Back to mapMap
Discussion
Researcher · Charles University · Czechia

Ivan Spicka

Ivan Spicka publishes mostly in Hematology, Oncology and Molecular Biology, on topics such as Multiple Myeloma Research and Treatments, Peptidase Inhibition and Analysis and Chronic Myeloid Leukemia Treatments.

ORCID 0000-0002-5451-5283 OpenAlex
World rank
#2,127,564
of 7,710,434 ranked researchers
Rank in Czechia
#4,725
of 39,303
Works
16
Citations
474
Citations per work
29.6
h-index
4
i10-index 2Top 93% in Hematology
Ivan Spicka

What does Ivan Spicka research?

Ivan Spicka's work is mostly in Medicine (71%), Biochemistry, Genetics and Molecular Biology (12%), Immunology and Microbiology (5%).

Health Sciences: 11 works · 71.4% of their workMedicine: 11 works · 71.4% of their workHematology: 7 works · 45.2% of their workOncology: 2 works · 14.3% of their workRadiology, Nuclear Medicine and Imaging: 2 works · 9.5% of their workPulmonary and Respiratory Medicine: 0 works · 2.4% of their workLife Sciences: 3 works · 16.7% of their workBiochemistry, Genetics and Molecular Biology: 2 works · 11.9% of their workMolecular Biology: 2 works · 11.9% of their workImmunology and Microbiology: 1 works · 4.8% of their workImmunology: 1 works · 4.8% of their workEverything else: 2 works · 11.9% of their workTHEIR WORKIvan Spicka16works
Life Sciences17%Health Sciences71%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine1171.4%
    1. Biochemistry, Genetics and Molecular Biology211.9%
    2. Immunology and Microbiology14.8%
  3. Everything else211.9%
  1. 1Hematology45% of their works
  2. 2Oncology14% of their works
  3. 3Molecular Biology12% of their works
  4. 4Radiology, Nuclear Medicine and Imaging10% of their works
  5. 5Immunology5% of their works
  6. 6Pulmonary and Respiratory Medicine2% of their works

Research topics

Which keywords describe Ivan Spicka's research?

The keywords of their largest research topics: Proteasome Inhibitors, Diagnosis Criteria, International Myeloma Working Group, PET Imaging, Cancer Therapy, Fibroblast Activation Protein, Tumor Microenvironment and BCR-ABL.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 19 words, with their numbers
  1. Proteasome Inhibitors172 topics
  2. Diagnosis Criteria151 topic
  3. International Myeloma Working Group151 topic
  4. PET Imaging72 topics
  5. Cancer Therapy62 topics
  6. Fibroblast Activation Protein41 topic
  7. Tumor Microenvironment41 topic
  8. BCR-ABL31 topic
  9. Imatinib31 topic
  10. Radiopharmaceuticals31 topic
  11. Targeted Therapy31 topic
  12. BET Bromodomains21 topic
  13. Chemotherapy-Induced Peripheral Neuropathy21 topic
  14. Dendritic Cells21 topic
  15. Immunity21 topic
  16. PROTACs21 topic
  17. Proteasome21 topic
  18. Taxanes21 topic
  19. Ubiquitin21 topic

Where does Ivan Spicka work?

Ivan Spicka's main affiliation in the publication record is Charles University, Czechia.

How many publications and citations does Ivan Spicka have?

OpenAlex counts 16 works and 474 citations for Ivan Spicka, an h-index of 4, ranking #2,127,564 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Other researchers named Ivan Spicka

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Ivan Spicka. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.